Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England

BACKGROUND: Trials of novel agents are required to improve the care of patients with rare diseases, but trial feasibility may be uncertain due to concerns over insufficient patient numbers. We aimed to determine the size of the pool of potential participants in England 2015–2017 for trials in the au...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, M. S. M., Harman, K. E., Thomas, K. S., Chalmers, J. R., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Gran, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863423/
https://www.ncbi.nlm.nih.gov/pubmed/33541270
http://dx.doi.org/10.1186/s12874-021-01212-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863423/
https://www.ncbi.nlm.nih.gov/pubmed/33541270
http://dx.doi.org/10.1186/s12874-021-01212-1

Ejemplares similares